Sarepta Therapeutics’ (SRPT) New Gene Therapy Unit Is Promising – Nomura – StreetInsider.com
StreetInsider.com |
Sarepta Therapeutics' (SRPT) New Gene Therapy Unit Is Promising – Nomura
StreetInsider.com Nomura/Instinet analyst, Christopher Marai, reiterated his Buy rating on shares of Sarepta Therapeutics (NASDAQ: SRPT) after the company announced the appointment of Dr. Rodino-Klapac as the company's Vice President of a newly created gene–therapy … |
